Form 8.3 - Aon plc
BARCLAYS PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | AON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 13 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: |
ORD |
|
|
||
Long |
Short |
||||
Number |
(%) |
Number |
(%) | ||
(1) |
Relevant securities |
|
|
|
|
454,519 |
0.20% |
1,719,017 |
0.76% |
||
|
|
|
|||
(2) |
Derivatives (other than options): |
|
|
|
|
101,570 |
0.04% |
13,691 |
0.01% |
||
|
|
|
|||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: |
24,200 |
0.01% |
24,200 |
0.01% |
|
|
|
|
|||
TOTAL: |
|
|
|
||
580,289 |
0.26% |
1,756,908 |
0.78% |
||
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit |
Purchase |
2 |
239.1225 USD |
Purchase |
2 |
239.2200 USD |
Purchase |
3 |
239.1600 USD |
Purchase |
4 |
239.1400 USD |
Purchase |
5 |
239.3000 USD |
Purchase |
6 |
239.0325 USD |
Purchase |
6 |
239.2250 USD |
Purchase |
6 |
239.2725 USD |
Purchase |
6 |
239.1816 USD |
Purchase |
8 |
239.4350 USD |
Purchase |
8 |
239.4400 USD |
Purchase |
11 |
239.2300 USD |
Purchase |
18 |
239.2100 USD |
Purchase |
21 |
239.2000 USD |
Purchase |
38 |
239.0800 USD |
Purchase |
48 |
239.3100 USD |
Purchase |
57 |
238.9100 USD |
Purchase |
96 |
237.0300 USD |
Purchase |
100 |
237.4500 USD |
Purchase |
100 |
238.2900 USD |
Purchase |
172 |
238.6460 USD |
Purchase |
180 |
238.3100 USD |
Purchase |
186 |
238.6159 USD |
Purchase |
200 |
239.3200 USD |
Purchase |
205 |
238.9821 USD |
Purchase |
250 |
238.7600 USD |
Purchase |
255 |
237.9629 USD |
Purchase |
345 |
238.8092 USD |
Purchase |
700 |
238.8364 USD |
Purchase |
801 |
239.4118 USD |
Purchase |
1,038 |
239.1580 USD |
Purchase |
1,112 |
239.3195 USD |
Purchase |
1,315 |
237.6715 USD |
Purchase |
1,483 |
238.9442 USD |
Purchase |
1,483 |
238.9441 USD |
Purchase |
1,591 |
239.3543 USD |
Purchase |
1,713 |
239.2845 USD |
Purchase |
1,907 |
239.2873 USD |
Purchase |
2,152 |
239.1657 USD |
Purchase |
2,731 |
239.3221 USD |
Purchase |
5,358 |
239.3149 USD |
Purchase |
5,400 |
238.6111 USD |
Purchase |
5,707 |
238.7928 USD |
Purchase |
6,427 |
238.5702 USD |
Purchase |
6,792 |
239.2398 USD |
Purchase |
10,573 |
238.4680 USD |
Purchase |
10,835 |
237.9155 USD |
Purchase |
11,847 |
238.9151 USD |
Purchase |
19,417 |
238.9471 USD |
Purchase |
25,338 |
239.3043 USD |
Purchase |
26,689 |
239.2400 USD |
Purchase |
37,823 |
239.0638 USD |
Purchase |
41,600 |
238.0208 USD |
Sale |
4 |
237.8700 USD |
Sale |
4 |
239.1225 USD |
Sale |
9 |
239.1800 USD |
Sale |
17 |
239.0358 USD |
Sale |
18 |
239.2100 USD |
Sale |
19 |
239.2081 USD |
Sale |
36 |
238.2311 USD |
Sale |
38 |
239.0800 USD |
Sale |
44 |
238.7590 USD |
Sale |
44 |
238.3145 USD |
Sale |
52 |
238.3061 USD |
Sale |
56 |
238.4357 USD |
Sale |
62 |
238.5400 USD |
Sale |
76 |
237.5098 USD |
Sale |
86 |
238.6700 USD |
Sale |
100 |
237.1800 USD |
Sale |
100 |
237.4500 USD |
Sale |
100 |
238.2900 USD |
Sale |
100 |
239.0410 USD |
Sale |
100 |
239.0450 USD |
Sale |
100 |
239.0600 USD |
Sale |
100 |
239.0700 USD |
Sale |
100 |
239.2300 USD |
Sale |
100 |
239.3200 USD |
Sale |
100 |
239.3900 USD |
Sale |
120 |
239.1733 USD |
Sale |
124 |
239.0206 USD |
Sale |
141 |
239.2700 USD |
Sale |
147 |
238.4311 USD |
Sale |
151 |
238.8707 USD |
Sale |
172 |
238.6460 USD |
Sale |
175 |
237.5300 USD |
Sale |
200 |
237.7500 USD |
Sale |
200 |
237.5200 USD |
Sale |
200 |
238.3900 USD |
Sale |
200 |
238.7200 USD |
Sale |
212 |
238.9296 USD |
Sale |
218 |
238.8453 USD |
Sale |
226 |
237.1446 USD |
Sale |
232 |
239.0834 USD |
Sale |
300 |
239.3683 USD |
Sale |
300 |
239.1533 USD |
Sale |
304 |
238.5972 USD |
Sale |
372 |
239.1208 USD |
Sale |
421 |
238.7025 USD |
Sale |
479 |
237.4932 USD |
Sale |
500 |
238.5940 USD |
Sale |
522 |
239.2386 USD |
Sale |
552 |
238.9550 USD |
Sale |
585 |
237.5180 USD |
Sale |
672 |
238.5846 USD |
Sale |
729 |
239.1549 USD |
Sale |
1,007 |
239.2380 USD |
Sale |
1,102 |
238.8317 USD |
Sale |
1,306 |
237.9566 USD |
Sale |
1,319 |
238.0065 USD |
Sale |
1,400 |
239.2510 USD |
Sale |
1,483 |
238.9441 USD |
Sale |
1,516 |
239.1785 USD |
Sale |
1,867 |
237.4004 USD |
Sale |
2,134 |
238.6045 USD |
Sale |
2,378 |
238.6441 USD |
Sale |
2,472 |
238.4009 USD |
Sale |
2,696 |
238.6626 USD |
Sale |
2,815 |
237.5128 USD |
Sale |
2,979 |
239.0094 USD |
Sale |
3,133 |
237.3902 USD |
Sale |
3,533 |
238.6057 USD |
Sale |
4,306 |
238.9911 USD |
Sale |
6,577 |
238.2043 USD |
Sale |
8,158 |
237.9565 USD |
Sale |
8,597 |
238.5939 USD |
Sale |
8,855 |
238.5044 USD |
Sale |
11,149 |
237.3269 USD |
Sale |
12,069 |
239.0456 USD |
Sale |
17,682 |
239.2400 USD |
Sale |
36,091 |
239.1448 USD |
Sale |
77,451 |
239.1082 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: |
14 Apr 2021 |
Contact name: |
Large Holdings Regulatory Operations |
Telephone number: |
020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or |
Number of |
Exercise | Type | Expiry |
purchased |
relevant securities |
price | date | ||
to which the option |
|||||
or derivative |
|||||
relates |
|||||
Put Options | Purchased |
-1,200 |
220.0000 |
American | Jul 16, 2021 |
Call Options | Purchased |
1,200 |
240.0000 |
American | Jul 16, 2021 |
Call Options | Purchased |
23,000 |
220.0000 |
American | Jul 16, 2021 |
Put Options | Purchased |
-23,000 |
200.0000 |
American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005451/en/